Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
2.85    0.10 (3.64%)
Bid:
2.75
Ask:
2.85
Spread: 0.10 (3.636%)
Market Cap: £5.20m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

Director Declaration

19 Mar 2020 15:00

RNS Number : 8513G
Nanoco Group PLC
19 March 2020
 

19 March 2020

NANOCO GROUP PLC

("Nanoco", the "Group", or the "Company")

 

Director Declaration

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from our technology platform, makes the following announcement.

In accordance with Listing Rule 9.6.14 the Company announces that Non-Executive Director, Dr Alison Fielding is to take up a non-executive director role with Zotefoams plc with effect from 14 May 2020.

There are no further disclosures required to be made in respect of Rule 9.6.13 of the Listing Rules.

For further information, please contact:

 

Nanoco

Tel: +44 (0) 161 603 7900

Brian Tenner, Company Secretary

Caroline Watson, Investor Relations Manager

Tel: + 44 (0) 7799 897357

cwatson@nanocotechnologies.com

 

Notes for editors:

 

About Nanoco Group plc

Nanoco (LSE: NANO) harnesses the power of nano-materials. Nano-materials are materials with dimensions typically in the range 1 - 100 nm. Nano-materials have a range of useful properties, including optical and electronic. Quantum dots are a subclass of nano-material that have size-dependent optical and electronic properties. The Group produces quantum dots. Within the sphere of quantum dots, the Group exploits different characteristics of the quantum dots to target different performance criteria that are attractive to specific markets or end-user applications such as the Display and Electronics markets. One of the interesting properties of quantum dots is photoluminescence: the emission of longer wavelength light upon excitation by light of a shorter wavelength. The colour of light emitted depends on the particle size. Nanoco's CFQD® quantum dots are free of cadmium and other toxic heavy metals, and can be tuned to emit light at different wavelengths across the visible and infrared spectrum, rendering them useful for a wide range of applications including displays, lighting and biological imaging.

Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany and Wah Hong Industrial Corporation of Taiwan.

Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.

Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

 

- Ends -

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RDNBSGDXDUBDGGC
Date   Source Headline
19th Dec 20171:11 pmRNSHolding(s) in Company
18th Dec 20171:24 pmRNSHolding(s) in Company
12th Dec 201712:07 pmRNSSecond Price Monitoring Extn
12th Dec 201712:02 pmRNSPrice Monitoring Extension
7th Dec 20177:00 amRNSDirector/PDMR Shareholding
4th Dec 20177:00 amRNSCommercial Supply and License Agreement
30th Nov 20174:43 pmRNSSecond Price Monitoring Extn
30th Nov 20174:35 pmRNSPrice Monitoring Extension
30th Nov 201712:31 pmRNSHolding(s) in Company
30th Nov 20177:00 amRNSAnnual Financial Report
16th Nov 20174:50 pmRNSHolding(s) in Company
16th Nov 20177:00 amRNSPreliminary Results
15th Nov 201710:42 amRNSDirector/PDMR Shareholding
14th Nov 20171:38 pmRNSResult of General Meeting
14th Nov 20177:00 amRNSWebcast of Full Year Results
8th Nov 201712:08 pmRNSHolding(s) in Company
2nd Nov 201710:35 amRNSHolding(s) in Company
1st Nov 20177:00 amRNSNotice of Results
31st Oct 201711:11 amRNSHolding(s) in Company
26th Oct 20173:59 pmRNSPublication of Circular and Notice of GM
5th Oct 20177:00 amRNSResults of placing
4th Oct 20174:40 pmRNSProposed fundraising of £8.6 million
19th Sep 20173:13 pmRNSNanoco CFQD® Fine Color FilmT at Touch Taiwan 2017
8th Sep 201710:34 amRNSCommercial Supply and License Agreement
7th Sep 201712:07 pmRNSSecond Price Monitoring Extn
7th Sep 201712:02 pmRNSPrice Monitoring Extension
29th Aug 20177:00 amRNSHolding(s) in Company
25th Aug 20174:17 pmRNSHolding(s) in Company
25th Aug 201712:52 pmRNSHolding(s) in Company
25th Aug 20177:00 amRNSFull Year Trading Update and Outlook
9th Aug 20177:00 amRNSEuropean Commission to Prohibit Cadmium
4th Aug 20177:00 amRNSHolding(s) in Company
12th Jul 20177:00 amRNSDavid Yao joins Nanoco
7th Jul 20177:10 amRNSHolding(s) in Company
7th Jul 20177:00 amRNSHolding(s) in Company
5th Jul 20177:00 amRNSNanoco Awarded Grant from Innovate UK
3rd Jul 20173:33 pmRNSHolding(s) in Company
3rd Jul 20177:00 amRNSNanoco presents at Samsung QLED & HDR10 Summit
30th Jun 20178:00 amRNSTotal Voting Rights
30th Jun 20177:00 amRNSNanoco receives first commercial order
28th Jun 20174:16 pmRNSHolding(s) in Company
21st Jun 20179:18 amRNSHolding(s) in Company
14th Jun 20171:39 pmRNSHolding(s) in Company
14th Jun 20177:00 amRNSBlock listing Interim Review
22nd May 20178:50 amRNSHolding(s) in Company
22nd May 20177:00 amRNSNanoco and Kyulux Inc. Sign Agreement
15th May 20177:00 amRNSHolding(s) in Company
11th May 20171:57 pmRNSHolding(s) in Company
10th May 201710:11 amRNSHolding(s) in Company
20th Apr 20177:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.